Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Foravirumab (CR4098) is a monoclonal antibody targeting antigenic site III of the rabies virus glycoprotein [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | Inquiry | |
5 mg | Inquiry | Inquiry |
Description | Foravirumab (CR4098) is a monoclonal antibody targeting antigenic site III of the rabies virus glycoprotein [1]. |
In vitro | Foravirumab (CR4098) recognizes an epitope located at antigenic site III. It retains binding to the mutated glycoprotein (N336D) expressed on PER.C6 cells. Foravirumab exhibits neutralizing potency and breadth comparable to CR57, including neutralization of CR57 escape mutants [1]. |
In vivo | In Syrian hamsters carrying the natural rabies virus, Foravirumab (CR4098; at doses of 10, 20, and 40 IU/kg) can prevent fatal infections of the natural rabies virus [1]. |
Synonyms | CR4098 |
Molecular Weight | N/A |
CAS No. | 944548-38-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Foravirumab 944548-38-3 CR 4098 CR4098 CR-4098 inhibitor inhibit